Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's oesophagus

Leedham, S. J.; Preston, S. L.; McDonald, S. A. C.; Elia, G.; Bhandari, P.; Poller, D.; Harrison, A.; Novelli, M. A.; Jankowski, J. A.; Wright, N. A.
August 2008
Gut;Aug2008, Vol. 57 Issue 8, p1041
Academic Journal
Objectives: Current models of clonal expansion in human Barrett's oesophagus are based upon heterogenous, flow- purified biopsy analysis taken at multiple segment levels. Detection of identical mutation fingerprints from these biopsy samples led to the proposal that a mutated clone with a selective advantage can clonally expand to fill an entire Barrett's segment at the expense of competing clones (selective sweep to fixation model). We aimed to assess clonality at a much higher resolution by microdissecting and genetically analysing individual crypts. The histogenesis of Barrett's metaplasia and neo- squamous islands has never been demonstrated. We investigated the oesophageal gland squamous ducts as the source of both epithelial sub-types. Methods: Individual crypts across Barrett's biopsy and oesophagectomy blocks were dissected. Determination of tumour suppressor gene loss of heterozygosity patterns, p16 and p53 point mutations were carried out on a crypt-by-crypt basis. Cases of contiguous neo-squamous islands and columnar metaplasia with oesophageal squamous ducts were identified. Tissues were isolated by laser capture microdissection and genetically analysed. Results: Individual crypt dissection revealed mutation patterns that were masked in whole biopsy analysis. Dissection across oesophagectomy specimens demonstrated marked clonal heterogeneity, with multiple independent clones present. We identified a p16 point mutation arising in the squamous epithelium of the oesophageal gland duct, which was also present in a contiguous metaplastic crypt, whereas neo-squamous islands arising from squamous ducts were wild-type with respect to surrounding Barrett's dysplasia. Conclusions: By studying clonality at the crypt level we demonstrate that Barrett's heterogeneity arises from multiple independent clones, in contrast to the selective sweep to fixation model of clonal expansion previously described. We suggest that the squamous gland ducts situated throughout the oesophagus are the source of a progenitor cell that may be susceptible to gene mutation resulting in conversion to Barrett's metaplastic epithelium. Additionally, these data suggest that wild-type ducts may be the source of neo-squamous islands.


Related Articles

  • Prognostic significance of KRAS gene mutations in colorectal cancer - preliminary study. Dinu, D.; Dobre, M.; Panaitescu, E.; Bîrlă, R.; Iosif, C.; Hoara, P.; Caragui, A.; Boeriu, M.; Constantinoiu, S.; Ardeleanu, C. // Journal of Medicine & Life;Oct-Dec2014, Vol. 7 Issue 4, p581 

    Objective: The prognostic significance of KRAS gene mutations, evaluated by using two methods in patients with colorectal cancer (CRC). Material and Methods: Retrospective study involving 58 patients diagnosed with CRC and treated between 2003 and 2010 in the General and Esophageal Surgery...

  • Genetics of Gastroesophageal Cancer: Paradigms, Paradoxes, and Prognostic Utility. Robertson, Elaine V.; Jankowski, Janusz A. // American Journal of Gastroenterology;Feb2008, Vol. 103 Issue 2, p443 

    Hereditary diffuse gastric cancer and tylosis are autosomal dominant cancer susceptibility syndromes. Accumulating evidence also suggests a genetic contribution to Barrett's esophagus and adenocarcinoma, traditionally considered acquired disorders. In this article we review the current knowledge...

  • Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett's esophagus. Streppel, M M; Lata, S; DelaBastide, M; Montgomery, E A; Wang, J S; Canto, M I; Macgregor-Das, A M; Pai, S; Morsink, F H M; Offerhaus, G J; Antoniou, E; Maitra, A; McCombie, W R // Oncogene;1/16/2014, Vol. 33 Issue 3, p347 

    The incidence of Barrett's esophagus (BE)-associated esophageal adenocarcinoma (EAC) is increasing. Next-generation sequencing (NGS) provides an unprecedented opportunity to uncover genomic alterations during BE pathogenesis and progression to EAC, but treatment-naive surgical specimens are...

  • Frequent Occurrence of Mitochondrial DNA Mutations in Barrett's Metaplasia without the Presence of Dysplasia. Soong Lee; Moon-Jong Han; Ki-Sang Lee; Seung-Chul Back; David Hwang; Hwan-Young Kim; Jong-Hee Shin; Soon-Pal Suh; Dong-Wook Ryang; Hye-Ran Kim; Myung-Geun Shin // PLoS ONE;May2012, Vol. 7 Issue 5, p1 

    Background: Barrett's esophagus (BE) is one of the most common premalignant lesions and can progress to esophageal adenocarcinoma (EA). The numerous molecular events may play a role in the neoplastic transformation of Barrett's mucosa such as the change of DNA ploidy, p53 mutation and alteration...

  • The Presence of Genetic Mutations at Key Loci Predicts Progression to Esophageal Adenocarcinoma in Barrett's Esophagus. Eluri, Swathi; Brugge, William R; Daglilar, Ebubekir S; Jackson, Sara A; Styn, Mindi A; Callenberg, Keith M; Welch, Derek C; Barr, Todd M; Duits, Lucas C; Bergman, Jacques J; Shaheen, Nicholas J // American Journal of Gastroenterology;Jun2015, Vol. 110 Issue 6, p828 

    OBJECTIVES:Risk stratification in Barrett's esophagus (BE) is challenging. We evaluated the ability of a panel of genetic markers to predict progression to high-grade dysplasia (HGD) or esophageal adenocarcinoma (EAC).METHODS:In this case-control study, we assessed a measure of genetic...

  • Atypical Regenerative Hyperplasia of the Esophagus in Endoscopic Biopsy. Arista-Nasr, Julián; Rivera, Irene; Martinez-Benitez, Braulio; Bornstein-Quevedo, Leticia; Orozco, Héctor; Lugo-Guevara, Yadira // Archives of Pathology & Laboratory Medicine;Jul2005, Vol. 129 Issue 7, p899 

    Context.—Atypical regeneration can mimic carcinoma in various epithelia. On endoscopic biopsies, atypical regenerative hyperplasia of the esophagus may show pleomorphism and atypia, simulating esophageal squamous cell carcinoma. Objective.—To establish the most useful histologic...

  • Barrett's Esophagus, High-Grade Dysplasia, and Early Adenocarcinoma: A Pathological Study. Cameron, Alan J.; Carpenter, Herschel A. // American Journal of Gastroenterology;Apr1997, Vol. 92 Issue 4, p586 

    Objectives: In Barrett's esophagus, early adenocarcinomas are often missed on endoscopic biopsy. We therefore examined the distribution and extent of dysplasia and carcinoma in the resected esophagus for comparison with the preoperative biopsy findings. Methods: Patients whose endoscopy showed...

  • Predictors of Progression in Barrett's Esophagus III: Baseline Flow Cytometric Variables. Rabinovitch, Peter S.; Longton, Gary; Blount, Patricia L.; Levine, Douglas S.; Reid, Brian J. // American Journal of Gastroenterology;Nov2001, Vol. 96 Issue 11, p3071 

    OBJECTIVES: Barrett's esophagus develops in 5-10% of patients with gastroesophageal reflux disease and predisposes to esophageal adenocarcinoma. We have previously shown that a systematic baseline endoscopic biopsy protocol using flow cytometry with histology identifies subsets of patients with...

  • Barrett's esophagus: A review of diagnostic criteria, clinical surveillance practices and new developments. Booth, Cassie L.; Thompson, Kevin S. // Journal of Gastrointestinal Oncology;2012, Vol. 3 Issue 3, p232 

    Barrett's esophagus is defined by metaplastic glandular changes to the distal esophagus and is linked to an increased risk of esophageal adenocarcinoma. Controversy exists whether the definition should be limited to intestinal type glands with goblet cells or should be expanded to include...


Read the Article


Sign out of this library

Other Topics